The associations between immune status, inflammation and sarcopenia in gastric cancer: a prospective cohort study

Status

Recruiting

Phases

Early Phase 1

Study type

Observational

Source

ChiCTR

Registry ID

ChiCTR1900026578

Enrollment

Unknown

Registered

2019-10-14

Start date

2019-10-31

Completion date

Unknown

Last updated

2021-03-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Gastric cancer and sarcopenia

Interventions

prospective cohort:none

Eligibility

Sex/Gender

All

Age

18 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1. Patients diagnosed with gastric cancer at TNM stage I-III; 2. Patients aged 18-80 years old; 3. Suitable for gastric cancer surgery; 4. Without obvious upper digestive tract obstruction.

Exclusion criteria

Exclusion criteria: 1. Patients with metastatic gastric cancer and at TNM stage IV; 2. Unable to receive an operation; 3. With severe cardiovascular diseases or infectious diseases; 4. With other malignant tumors.

Design outcomes

Primary

Measure	Time frame
skeletal muscle weight loss;	—

Secondary

Measure	Time frame
body weight loss;	—

Countries

China

Contacts

Public ContactWu Xiaoting

West China Hospital, Sichuan University

wxt1@medmail.com.cn+86 18980601493

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026